Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-07-11

Clinical Trial Update: Relationship Between Immunity and Metabolism in Patients Receiving Immune Checkpoint Inhibitors for Advanced Cancer. ( RIMEC ) [NA]

View source ↗

Summary

The trial examines the relationship between immunity and metabolism in patients with advanced cancer receiving immune checkpoint inhibitors. The study (NCT04808…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Metabolism Disorder, Cancer | NA | Status: ACTIVE_NOT_RECRUITING